-
Indian pharma faces challenge from Trump tariffs and US regulators
The US is the third largest importer of drugs made in India. But President Trump’s tariffs plan could derail bilateral trade ties.
-
FCA work in review: March 25-April 1, 2025
Our at-a-glance guide to a busy week of FCA activity.
-
Reeves promises new legislation around reporting rules for UK firms
The announcement is another step in the government’s broader agenda to reshape the UK regulatory landscape and decrease burden on businesses.
-
ASIC roundup: A$27m fine on AustralianSuper, and dismissed appeal
The Australian Securities & Investments Commission’s latest actions and news, February 10 – 21, 2025.
-
FCA wants firms to do more to disrupt money mule activity
Reporting of fraud by firms lagging offboarding of mules, but regulator notes high incidence of SARs reporting.
-
PRA to relax investment and reporting requirement rules for banks and insurers
New plans include retrospective authorization of investments, as well as cutting reporting requirements for banks.
-
GRIP’s ‘most read’ stories in 2024
Compliance and legal professionals will remember 2024 as a year of considerable regulatory activity, major developments in technology, and the inevitable, routine mistakes.
-
Understanding EU NIS2 Directive implementation delays
Reporting/registration requirements and the consequences for organizations in countries where implementation of the NIS2 Directive is delayed.